TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search results
Popular Reads
Top Results
No results found. Please check your search term and try again
Can't find what you're looking for?
View all search resultsKimia Farma acquires Dawaa in Mideast expansion bid
Change text size
Gift Premium Articles
to Anyone
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
A customer purchases products at a Kimia Farma drugstore in this undated photo. (Tribunnews/Tribunnews)
S
tate-owned pharmaceutical company PT Kimia Farma has announced its acquisition of Dawaa Medical Limited Company as an initial step to expanding its business in Saudi Arabia.
Under the acquisition terms, Kima Farma has taken over 60 percent of Dawaa shares worth 38 million Saudi riyal (US$10 million). The new name for the company is Kimia Farma Dawaa.
“It is an initial step to expand into Saudi Arabia with hopes of entering the African market,” Kimia Farma president director Honesty Basyir said in Jakarta on Monday, after the signing ceremony for the shares takeover agreement, kompas.com reported.
Honesty said the new acquisition in Saudi Arabia was part of its efforts to support the government’s initiative to improve healthcare services to Indonesian hajj pilgrims.
Honesty said that Al-Dawaa currently operates 31 drugstores, mostly in Mecca and Medina, and that following the acquisition, Kima Farma Dawaa would increase the number of drugstores to 90 outlets.
“We are expanding our business to Saudi Arabia because of its promising market," she added, saying that annual turnover could reach $20 billion by 2020. (bbn)
